The Fund had a strong second quarter, outperforming its benchmarks, the Russell 1000 Growth Index and the S&P 500 Index. Read ...

This paper presents important new findings about the impact of the TAK-003 vaccine against dengue based on a convincing reanalysis of trial data. The results corroborate those of the original trial ...

The browser you are using is no longer supported on this site. It is highly recommended that you use the latest versions of a supported browser in order to receive an optimal viewing experience. The ...